16．産学連携研究—企業の選択から研究費出願まで

Business-academia collaborative research

企業を立ち上げて産学連携を実践する医師としての立場から，5つの話題に触れる。

①産学連携研究前に特許申請は検討すべき。

②いわゆる100万円規定にかかわらないCOIの開示は研究の公正性を担保するうえで重要。

③医学研究の倫理指針は個人情報保護法の例外規定の枠内で運用されている。

④企業との協働時には当該企業の強みと一致した提案を持ち込むとよい。

⑤企業のかかわる大型研究費の獲得には要項の読み込みと採択事例の調査が重要。

This article discusses topics related to business-academia collaborative research based on my experiences as CEO of a Medical IT private institution and clinical investigator at a university / community hospital.

1. A patent application should be considered before conducting business-academia collaborative research.

2. Appropriate （not based on financial impact only） conflict of interest disclosures are important to fairly credit clinical research.

3. Understanding of personal information protection laws and Ethical Guidelines for Medical and Biological Research Involving Human Subjects and their relationship is important for conducting collaborative research.

4. When discussing with private companies about collaborative research, it is important to know about each company's advantages,.

5. Essential tips for applying for relatively large research funds targeted for collaborative research.